Effect of selenium and Q10 on the cardiac biomarker NT-proBNP

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Scandinavian Cardiovascular Journal

• Publication date

  2013-09-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/14017431.2013.820838PMID 23895165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved health-related quality of life, and more days out of hospital with supplementation with selenium and coenzyme Q10 combined. Results from a double blind, placebo-controlled prospective study

  2015cited by this paper
• Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

  2013cited by this paper
• Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis.

  2013cited by this paper
• Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease.

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.

  2012cited by this paper
• Relationship between plasma concentrations of N‐terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP‐CHF study

  2012influential reference
• Selenium in Human Health and Disease

  2011cited by this paper
• Aging and Cardiac Fibrosis.

  2011cited by this paper
• Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

  2010cited by this paper
• Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study.

  2010cited by this paper
• Rosuvastatin in older patients with systolic heart failure.

  2009cited by this paper
• Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy

  2008cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡

  2008cited by this paper
• Coenzyme Q10: an independent predictor of mortality in chronic heart failure.

  2008cited by this paper
• Rosuvastatin in older patients with systolic heart failure.

  2007cited by this paper
• The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.

  2006influential reference
• Selenoproteins, cholesterol-lowering drugs, and the consequences: revisiting of the mevalonate pathway.

  2004influential reference
• Elevated circulating levels of thioredoxin and stress in chronic heart failure

  2004cited by this paper
• Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end‐points of “Q‐symbio” ‐ A multinational trial

  2003cited by this paper
• The Mammalian Cytosolic Selenoenzyme Thioredoxin Reductase Reduces Ubiquinone

  2003cited by this paper
• Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care.

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Coenzyme Q10 in health and disease

  1999cited by this paper
• Determinants of plasma coenzyme Q10 in humans

  1999cited by this paper
• Ubiquinone biosynthesis by the microsomal fraction from rat liver.

  1987cited by this paper
• Cardiovascular Mortality and N-terminal- Probnp Reduced after Combined Selenium and Coenzyme Q10 Supplementation: a 5-year Prospective Randomized Double-blind Placebo- Controlled Trial among Elderly Swedish Citizens Cardiovascular Mortality and N-terminal-probnp Reduced after Combined Selenium and C

  year unknowninfluential reference

• Short-term CoQ10 supplementation reduces markers of cardiac stress in soccer players following heavy exercise: A randomized double-blind placebo-controlled trial

  2025cites this paper
• The Ubiquinone-Ubiquinol Redox Cycle and Its Clinical Consequences: An Overview

  2024cites this paper
• Selenium and coenzyme Q10 improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals.

  2023cites this paper
• Refractory Hypotension Caused by Selenium Deficiency in a Patient on Peritoneal Dialysis

  2021cites this paper
• Coenzyme Q10 for heart failure.

  2021cites this paper
• Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis

  2020cites this paper
• Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population

  2019cites this paper
• Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable

  2019cites this paper
• Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview

  2019cites this paper
• CoQ10 + Selenium Yeast

  2018cites this paper
• Coenzyme Q10 deficiency in elderly: Can nutritional supplementation play a role? Mini review

  2018cites this paper
• Prevention of "nitrosative stress" by a nutritional supplement (LaVita®) - a randomized placebo controlled double blind clinical trial with healthy volunteers.

  2016cites this paper
• Coenzyme Q10 — A new player in the treatment of heart failure?

  2016cites this paper
• Association between serum level of ubiquinol and NT-proBNP, a marker for chronic heart failure, in healthy elderly subjects.

  2015cites this paper
• Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial

  2015cites this paper
• Less increase of copeptin and MR-proADM due to intervention with selenium and coenzyme Q10 combined: Results from a 4-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

  2015cites this paper
• Selenium and coenzyme Q10 interrelationship in cardiovascular diseases--A clinician's point of view.

  2015cites this paper
• Improved health-related quality of life, and more days out of hospital with supplementation with selenium and coenzyme Q10 combined. Results from a double blind, placebo-controlled prospective study

  2015cites this paper
• Coenzyme Q10 and congestive heart failure; an evolving evidence base.

  2015cites this paper
• INDIVIDUAZIONE E CARATTERIZZAZIONE DI UNA SOTTOPOPOLAZIONE CON PATTERN GENETICO PREDISPONENTE AD UN ALTO RISCHIO CARDIOVASCOLARE.

  2013cites this paper